| Allograft |
Human donor bone tissue, processed for clinical use. |
Granules, chips, blocks, or other forms depending on the product. |
Used in selected bone-repair procedures; suitability depends on the product and clinical indication. |
Applicable authorization, donor-tissue sourcing and screening information, processing details, traceability, and storage requirements. |
| Xenograft |
Animal-derived mineralized tissue, commonly processed to remove organic components. |
Granules, blocks, or shaped graft pieces. |
Used as a bone-graft substitute in selected dental, oral, maxillofacial, or orthopedic procedures, depending on its approved use. |
Animal source, manufacturing and purification process, applicable product authorization, sterilization method, and labeled indications. |
| Hydroxyapatite (HA) |
Calcium-phosphate ceramic with a composition similar to the mineral component of bone. |
Granules, porous blocks, or shaped ceramic components. |
Used in selected bone-defect filling and reconstruction applications; performance depends on formulation and design. |
Composition, porosity, particle-size range, mechanical properties where relevant, sterilization, and product-specific authorization. |
| Beta-tricalcium phosphate (β-TCP) |
Synthetic calcium-phosphate ceramic. |
Granules, porous blocks, or other molded forms. |
Used as a resorbable bone-graft substitute in selected indications; resorption characteristics vary by product. |
Material composition, porosity, resorption-related product data, sterilization, shelf life, and labeled indications. |
| HA/β-TCP composite |
A synthetic composite combining hydroxyapatite and beta-tricalcium phosphate; proportions vary by product. |
Granules, porous blocks, or shaped graft substitutes. |
Designed for selected bone-repair applications; properties depend on composition and manufacturing process. |
Component ratio, material characterization, product-specific performance data, sterilization, and regulatory documentation. |
| Bioactive glass |
Silicate-based glass containing oxides such as silica, calcium, sodium, or phosphorus; formulation varies. |
Particles, granules, or other product-specific forms. |
Used in selected bone-graft or bone-defect applications where the product is indicated. |
Glass composition, particle characteristics, clinical evidence relevant to the intended use, sterilization, and applicable authorization. |
| Collagen-based composite |
Collagen combined with a mineral component or another graft material; source and formulation vary. |
Moldable strips, plugs, granules, or composite forms. |
May be used as a handling aid or graft substitute in selected procedures, subject to product labeling. |
Collagen source, composition, biological-safety documentation, handling instructions, storage conditions, and labeled indications. |